The National Heart, Lung, and Blood Institute (NHLBI) is now participating in the NOSI for  Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health (NOT-EB-21-001). The NHLBI is interested in projects focused on detecting, predicting, and/or monitoring HLBS disorders during pregnancy and/or the post-partum period, as well as projects that enhance the monitoring and management of women with existing HLBS-specific disorders and risk factors who enter pregnancy or are considering becoming pregnant.